[go: up one dir, main page]

AU6922891A - Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol - Google Patents

Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol

Info

Publication number
AU6922891A
AU6922891A AU69228/91A AU6922891A AU6922891A AU 6922891 A AU6922891 A AU 6922891A AU 69228/91 A AU69228/91 A AU 69228/91A AU 6922891 A AU6922891 A AU 6922891A AU 6922891 A AU6922891 A AU 6922891A
Authority
AU
Australia
Prior art keywords
dihydroxycholecalciferol
alpha
relating
compositions containing
topical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU69228/91A
Other versions
AU629445B2 (en
Inventor
Subhas Chandra Kundu
Noel Mark Meltzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU6922891A publication Critical patent/AU6922891A/en
Application granted granted Critical
Publication of AU629445B2 publication Critical patent/AU629445B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Reinforced Plastic Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The stability of topical pharmaceutical preparations in emulsion form with 1 alpha ,25-dihydroxycholecalciferol as active ingredient is increased when the pH of the preparation is 6.5 - 7.5.
AU69228/91A 1990-01-10 1991-01-08 Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol Ceased AU629445B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46310290A 1990-01-10 1990-01-10
US463102 1990-01-10

Publications (2)

Publication Number Publication Date
AU6922891A true AU6922891A (en) 1991-07-11
AU629445B2 AU629445B2 (en) 1992-10-01

Family

ID=23838868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69228/91A Ceased AU629445B2 (en) 1990-01-10 1991-01-08 Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol

Country Status (14)

Country Link
EP (1) EP0437225B1 (en)
JP (1) JPH0739345B2 (en)
AT (1) ATE104554T1 (en)
AU (1) AU629445B2 (en)
CA (1) CA2033726A1 (en)
DE (1) DE59101404D1 (en)
DK (1) DK0437225T3 (en)
FI (1) FI910112A7 (en)
IE (1) IE65371B1 (en)
IL (1) IL96903A (en)
NO (1) NO178286C (en)
NZ (1) NZ236710A (en)
PH (1) PH27567A (en)
ZA (1) ZA91115B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667742B2 (en) * 1992-09-18 1996-04-04 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684681A5 (en) * 1992-09-03 1994-11-30 Keane Jr & Cie coricide composition.
DE19549243A1 (en) * 1995-12-21 1997-06-26 Schering Ag Pharmaceutical preparations containing clathrates of cyclodextrins and unnatural vitamin D analogues
CA2312060A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
KR20010032892A (en) * 1997-12-09 2001-04-25 나가야마 오사무 Creams containing vitamin d3 derivatives
WO2000059470A1 (en) * 1999-04-05 2000-10-12 Senju Pharmaceutical Co., Ltd. Emulsion and process for producing the same
EP1194109B1 (en) * 1999-06-25 2004-08-18 Durham Pharmaceuticals Ltd. Topical formulations comprising skin penetration agents and the use thereof
WO2002034235A1 (en) * 2000-10-27 2002-05-02 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
PL378172A1 (en) * 2003-02-05 2006-03-06 Galderma Research & Development, S.N.C. Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS6351312A (en) * 1986-08-20 1988-03-04 Pola Chem Ind Inc Skin beautifying cosmetic
JPS63145211A (en) * 1986-12-05 1988-06-17 Piasuaraizu Kk Vitamin-containing cosmetic
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667742B2 (en) * 1992-09-18 1996-04-04 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3
US5565442A (en) * 1992-09-18 1996-10-15 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3
US5804573A (en) * 1992-09-18 1998-09-08 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical composition containing derivative of vitamins D2 and D3

Also Published As

Publication number Publication date
FI910112L (en) 1991-07-11
PH27567A (en) 1993-08-18
AU629445B2 (en) 1992-10-01
JPH04210903A (en) 1992-08-03
NO910102D0 (en) 1991-01-09
FI910112A0 (en) 1991-01-09
EP0437225B1 (en) 1994-04-20
IL96903A0 (en) 1992-03-29
ZA91115B (en) 1991-09-25
CA2033726A1 (en) 1991-07-11
FI910112A7 (en) 1991-07-11
DK0437225T3 (en) 1994-06-27
NZ236710A (en) 1993-04-28
NO910102L (en) 1991-07-11
IL96903A (en) 1995-03-15
DE59101404D1 (en) 1994-05-26
EP0437225A1 (en) 1991-07-17
JPH0739345B2 (en) 1995-05-01
NO178286B (en) 1995-11-20
ATE104554T1 (en) 1994-05-15
NO178286C (en) 1996-02-28
IE65371B1 (en) 1995-10-18
IE910068A1 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
EP0255364A3 (en) Anhydrous cosmetic preparation
RU93047799A (en) COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL
AU4120689A (en) Cosmetic composition
AU6542986A (en) Pyridyl-methylthio substituted benzimidazoles
IE873125L (en) Benzimidazole derivatives
AU2726692A (en) Penetration enhancement of topically applied formulations
MX9304710A (en) PHARMACEUTICAL AND / OR COSMETIC COMPOSITION AND ITS USE.
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
AU6333794A (en) Retinoid composition
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
DK0615435T3 (en) Cosmetic Preparation
AU621763B2 (en) Stable tretinoin emulsified cream formulations
AU5629690A (en) Carboplatin composition
ES2089560T3 (en) COSMETIC AND DERMATOLOGICAL PREPARATIONS.
CA2047802A1 (en) Pharmaceutical compositions
NO902104D0 (en) COSMETIC MIXING.
ATE130754T1 (en) MOISTURIZING COSMETIC PREPARATIONS.
CA2075926A1 (en) Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
JPS6456622A (en) Percutaneous absorbefacient base composition
EP0155015A3 (en) Less-irritant hair-rinse composition
TW225993B (en) A composition prevention hair loss and promoting hair growth and its usage
SE9004076D0 (en) APPLICATION OF 10-ACETYL-1,8,9-TRIACETOXY ANTRACES AS ANTI-INFLAMMATOR AGENT IN PREPARATION OF PHARMACEUTICAL AND COSMETIC COMPOSITIONS

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired